Study of Aripiprazole (Abilify) in Children With Symptoms of Mania
Status:
Completed
Trial end date:
2011-01-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to look at the safety and effectiveness of aripiprazole
(abilify) in children with bipolar disorder and to examine whether or not patients that
respond to initial mood stabilization benefit from continued pharmacotherapy.